Aclidinium bromide/formoterol in COPD: Added benefit for certain patient groups
Tuesday, May 12, 2015 - 13:30
in Health & Medicine
Patients with COPD grade III with no more than one flare-up per year and grade II patients benefit from the new aclidinium Bromide/formoterol drug combination, researchers note.